Two confirmatory testing panels were used—the primary panel was betaxolol-glucagon (children ≥15 kg) or glucagon (<15 kg or asthma), and the secondary was arginine-insulin (children ≥15 kg) or arginine (children <15 kg). The gene discussed is GCG; the disease is asthma.